KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Dividends payables (2016 - 2025)

Pfizer (PFE) has disclosed Dividends payables for 17 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • Quarterly Dividends payables changed 0.33% to $2.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 billion through Dec 2025, changed 0.33% year-over-year, with the annual reading at $2.4 billion for FY2025, 0.33% changed from the prior year.
  • Dividends payables for Q4 2025 was $2.4 billion at Pfizer, roughly flat from $2.4 billion in the prior quarter.
  • The five-year high for Dividends payables was $2.4 billion in Q2 2025, with the low at $2.2 billion in Q3 2021.
  • Average Dividends payables over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2022.
  • The sharpest move saw Dividends payables rose 4.02% in 2021, then rose 0.33% in 2025.
  • Over 5 years, Dividends payables stood at $2.2 billion in 2021, then increased by 2.4% to $2.3 billion in 2022, then grew by 3.0% to $2.4 billion in 2023, then grew by 2.74% to $2.4 billion in 2024, then increased by 0.33% to $2.4 billion in 2025.
  • According to Business Quant data, Dividends payables over the past three periods came in at $2.4 billion, $2.4 billion, and $2.4 billion for Q4 2025, Q2 2025, and Q4 2024 respectively.